| HOME | MEETINGS | MEMBERSHIP | EXHIBITORS | AWARDS | INFO | NEWS | ABOUT US | CONTACT | SIGN IN |
ensuring knowledge, enhancing quality
A 'not-for-profit' organisation,
run for pharmaceutical analysts by pharmaceutical analysts
run for pharmaceutical analysts by pharmaceutical analysts
| HOME | MEETINGS | MEMBERSHIP | EXHIBITORS | AWARDS | INFO | NEWS | ABOUT US | CONTACT | SIGN IN |
NEXT EVENT: Thursday 21st March 2019 - Stability IV: Developments in stability testing and evaluation... 
JPAG - serving its members since 1970
JPAG plans and delivers events that address all aspects of pharmaceutical analysis and related facets of medicine control & registration.
NEXT EVENTS:
LAST EVENT:
JPAG plans and delivers events that address all aspects of pharmaceutical analysis and related facets of medicine control & registration.
NEXT EVENTS:
Thursday 21st March 2019
Stability IV: Developments in stability testing and evaluation
Royal Society of Chemistry, London
Continuing our successful series of stability meetings, this is an essential event for anyone concerned with the management and assessment of drug stability:
• Hear from individuals involved in the regulation and inspection of stability and GDP
• Learn from industry experts on scientific developments in stability study design and interpretation
• Debate practical issues for evaluating data and predicting stability
• Examine ways to improve compliance and productivity in stability testing
• Network with other professionals and exhibitors
Speakers:
Dr Jonathan Bright - AstraZeneca
John Cleverley - Clarivate Analytics
Dr Paul Fullerton - AMRI
Conor Jamieson - Sandwell and West Birmingham NHS Trust
Dr Rachel Orr - GlaxoSmithKline
Dr Garry Scrivens - Pfizer
Susan Smith - AstraZeneca
Dr Maria Krisch - Freethink Technologies Inc
DETAILS AND REGISTRATION
Stability IV: Developments in stability testing and evaluation
Royal Society of Chemistry, London
Continuing our successful series of stability meetings, this is an essential event for anyone concerned with the management and assessment of drug stability:
• Hear from individuals involved in the regulation and inspection of stability and GDP
• Learn from industry experts on scientific developments in stability study design and interpretation
• Debate practical issues for evaluating data and predicting stability
• Examine ways to improve compliance and productivity in stability testing
• Network with other professionals and exhibitors
Speakers:
Dr Jonathan Bright - AstraZeneca
John Cleverley - Clarivate Analytics
Dr Paul Fullerton - AMRI
Conor Jamieson - Sandwell and West Birmingham NHS Trust
Dr Rachel Orr - GlaxoSmithKline
Dr Garry Scrivens - Pfizer
Susan Smith - AstraZeneca
Dr Maria Krisch - Freethink Technologies Inc
DETAILS AND REGISTRATION
Thursday 21st March 2019
Annual General Meeting
Royal Society of Chemistry, London
This is a closed meeting for members of JPAG
It is not necessary to register for the symposium to attend the AGM
Starts at 9.30 am
Click here to see the Agenda
DETAILS AND REGISTRATION
Annual General Meeting
Royal Society of Chemistry, London
This is a closed meeting for members of JPAG
It is not necessary to register for the symposium to attend the AGM
Starts at 9.30 am
Click here to see the Agenda
DETAILS AND REGISTRATION
Thursday 9th May 2019
Assuring the quality of medicines III; aseptic products
Royal Society of Chemistry, London
The quality of Aseptic products is the most critical challenge in the pharmaceutical industry. It covers those medicinal products that cannot be terminally sterilised, the majority of new injectable IMPs and all gene therapy and ATMPs. In addition, 2019 is a vitally important year as the revised Annex 1 becomes globally implemented and provides a host of challenges for the industry trying to implement it. JPAG has been able to bring together a unique and almost unparalleled group of speakers in a programme that tries to cover the hottest topics in this field.
There will be adequate time after each presentation to discuss case studies and practical implications.
DETAILS AND REGISTRATION
Assuring the quality of medicines III; aseptic products
Royal Society of Chemistry, London
The quality of Aseptic products is the most critical challenge in the pharmaceutical industry. It covers those medicinal products that cannot be terminally sterilised, the majority of new injectable IMPs and all gene therapy and ATMPs. In addition, 2019 is a vitally important year as the revised Annex 1 becomes globally implemented and provides a host of challenges for the industry trying to implement it. JPAG has been able to bring together a unique and almost unparalleled group of speakers in a programme that tries to cover the hottest topics in this field.
There will be adequate time after each presentation to discuss case studies and practical implications.
DETAILS AND REGISTRATION
Thursday 11th July 2019
Analytical challenges of new modalities
Royal Society of Chemistry, London
The purpose of this symposium is to Identify areas for harmonisation of oligonucleotide development and propose solutions to influence the external regulatory environment; expediting patient access to revolutionary medicines
DETAILS AND REGISTRATION
Analytical challenges of new modalities
Royal Society of Chemistry, London
The purpose of this symposium is to Identify areas for harmonisation of oligonucleotide development and propose solutions to influence the external regulatory environment; expediting patient access to revolutionary medicines
DETAILS AND REGISTRATION
LAST EVENT:
COLLABORATIVE EVENT: Friday 8th February 2019
RPS Science & Research Summit
ETC.VENUES COUNTY HALL, LONDON
In collaboration with the Royal Pharmaceutical Society and the Academy of Pharmaceutical Sciences
Chaired by RPS Chief Scientist Gino Martini and featuring keynote speakers Dame Sally Davies and Professor Molly Stevens, the Science and Research Summit will showcase the latest ground-breaking developments in pharmacy, research and pharmaceutical sciences and debate some of the most pressing challenges and opportunities for the future of healthcare.
DETAILS
RPS Science & Research Summit
ETC.VENUES COUNTY HALL, LONDON
In collaboration with the Royal Pharmaceutical Society and the Academy of Pharmaceutical Sciences
Chaired by RPS Chief Scientist Gino Martini and featuring keynote speakers Dame Sally Davies and Professor Molly Stevens, the Science and Research Summit will showcase the latest ground-breaking developments in pharmacy, research and pharmaceutical sciences and debate some of the most pressing challenges and opportunities for the future of healthcare.
DETAILS
Our only sponsors are our parent professional bodies:
Delegates of any JPAG symposia can access the speakers presentations.
Just SIGN IN, go to RESOURCES and look in MY PAST MEETINGS.
Just SIGN IN, go to RESOURCES and look in MY PAST MEETINGS.
Missed the meeting?
You can access a short report of recent meetings!
Just go to the MEETINGS page, go to PAST EVENTS. Then select the DETAILS for the meeting that interests you.
And do be sure to check the list of upcoming meetings so that you don't miss the next one!
You can access a short report of recent meetings!
Just go to the MEETINGS page, go to PAST EVENTS. Then select the DETAILS for the meeting that interests you.
And do be sure to check the list of upcoming meetings so that you don't miss the next one!
European Pharmaceutical Review
JPAG members can receive a free hard copy subscription to EPR
click here
JPAG members can receive a free hard copy subscription to EPR
click here
TESTIMONIALS:
Very enjoyable and thought-provoking day; going away with plenty of notes and specific items for discussion.
Excellent meeting, challenging and thought provoking. The organisation was excellent, thanks to all the efforts that JPAG team have made.
I have not attended a bad JPAG meeting yet. They are really good value for money and I really love to get the presentations as PDFs
LATEST NEWS:
Brexit and balance
Here is another article in the series reproduced with permission from the European Pharmaceutical Review. It is entitled "Brexit and balance” written by Dr Dave Elder, Past-Chairman of the JPAG Committee More...
Thursday 31st January 2019
Here is another article in the series reproduced with permission from the European Pharmaceutical Review. It is entitled "Brexit and balance” written by Dr Dave Elder, Past-Chairman of the JPAG Committee More...
Thursday 31st January 2019
Mutagenic impurities: a done deal?
Here is another article in the series reproduced with permission from the European Pharmaceutical Review. It is entitled "Mutagenic impurities: a done deal?” written by Dr Dave Elder, Past-Chairman of the JPAG Committee More...
Thursday 31st January 2019
Here is another article in the series reproduced with permission from the European Pharmaceutical Review. It is entitled "Mutagenic impurities: a done deal?” written by Dr Dave Elder, Past-Chairman of the JPAG Committee More...
Thursday 31st January 2019
Understanding the importance of analytical Target Profile: the key...
Here is another article in the series reproduced with permission from the European Pharmaceutical Review. It is entitled "Understanding the importance of analytical Target Profile: the key questions to ask” written by Dr Dave Elder, Past-Chairman o...
More...
Thursday 31st January 2019
Here is another article in the series reproduced with permission from the European Pharmaceutical Review. It is entitled "Understanding the importance of analytical Target Profile: the key questions to ask” written by Dr Dave Elder, Past-Chairman o...
More...
Thursday 31st January 2019
COOKIES AND PERSONAL DATA:
This site does not use cookies.
However, it does securely hold details for those who register an account.
This information is only used by JPAG as described in the Privacy Statement (see link on footer below).
Follow us:
| Call us: | CONTACT US | Follow us: | | Terms and Conditions Privacy Statement |
| © Joint Pharmaceutical Analysis Group 2019 Website by Delta Consultancy Services |
|